PE

Pavithra Elangovan

Active Director Director DIN 11947751
DIN 11947751 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pavithra Elangovan

Pavithra Elangovan is a Director at Biove Life Sciences Private Limited (since 2026).

DIN 11947751
Primary Designation Director
First Appointment 15 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biove Life Sciences Private Limited U21009TN2026PTC197907
Director15 Sep 20262026Active

Board colleagues of Pavithra Elangovan

NameDINCompanyDesignation
Aravind Sachithanantham06545872Biove Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biove Life Sciences Private Limited
Premium access

Shareholding and investment profile for Pavithra Elangovan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavithra Elangovan

Pavithra Elangovan currently holds 1 directorship: Biove Life Sciences Private Limited (Director, since 15 Sep 2026).

Pavithra Elangovan was first appointed on 15 Sep 2026 as Director at Biove Life Sciences Private Limited.

The current boards of Pavithra Elangovan's companies include Aravind Sachithanantham (Biove Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available